PTT |
Ti3C2, Ti3C2 QDs, Ta4C3, Nb2C, MnOx/Ti3C2, MnOx/Ta4C3
|
High photothermal conversion performance (Nb2C: η = 36.5% (808 nm) or 46.65% (1064 nm), Ti3C2: η = 30.6%, and Ta4C3 = 44.7%), in vitro and in vivo photothermal ablation of tumor. |
45, 49, 51, 52, 131
|
Synergistic PTT/PDT/chemotherapy |
Ti3C2‐DOX |
Demonstrating stimuli‐responsive drug‐releasing behavior, superior photothermal conversion efficiency (η = 58.3%), and effective singlet oxygen generation (1O2), achieving effective cancer cell killing and tumor tissue destruction both in vitro and in vivo. |
52
|
PL imaging |
Ti3C2 QDs |
A biocompatible multicolor cellular imaging probe exhibiting excitation‐dependent PL spectra with quantum yields around 10%. |
53
|
MR imaging |
MnOx/Ti3C2, MnOx/Ta4C3
|
Tumor microenvironment‐responsive (pH‐responsive) contrast agents for T
1‐weighted MR imaging. |
46, 51
|
CT imaging |
Ta4C3, MnOx/Ta4C3
|
High atomic number of Ta component endows Ta4C3 MXene with contrast‐enhanced computed tomography imaging. |
46, 47
|
PA imaging |
MnOx/Ti3C2, Ta4C3, MnOx/Ta4C3, Nb2C |
High photothermal conversion performance of MXenes enables their potential PA imaging. |
46, 47, 49, 51
|
Biosensing |
Ti3C2
|
MXene‐micropattern‐based FET for probing neural activity, immobilizing hemoglobin (Hb) to fabricate a mediator‐free biosensor, amperometric glucose biosensor. |
54, 55, 56, 57
|
Antimicrobial activity |
Ti3C2, PVDF/Ti3C2 membrane |
Colloidal Ti3C2Tx solution exhibits antibacterial activity against E. coli and B. subtilis. |
58, 59
|
Biosafety/cytotoxicity |
Ti3C2, Ta4C3, Nb2C, MnOx/Ti3C2, MnOx/Ta4C3, Fe3O4/Ti3C2, Fe3O4/Ta4C3
|
Ecotoxicological assessments, cytotoxicities, and in vivo potential biosafety and biocompatibility |
45, 46, 47, 49, 50, 51, 78, 129, 132
|